Use this URL to cite or link to this record in EThOS: https://ethos.bl.uk/OrderDetails.do?uin=uk.bl.ethos.821737
Title: Development of a multiplex sensing platform for the accurate and rapid diagnosis of sepsis
Author: Demertzis, Nikolaos
ISNI:       0000 0005 0285 5675
Awarding Body: Cardiff University
Current Institution: Cardiff University
Date of Award: 2020
Availability of Full Text:
Access from EThOS:
Access from Institution:
Abstract:
Sepsis derives from an uncontrolled response of the host immune system to a pathogenic insult. The complex, rapidly evolving nature of the condition makes diagnosis difficult, and to date a single ‘gold-standard’ biomarker has not been reported. An increasing number of studies suggest that monitoring of a panel of biomarkers, ideally at point-of-care, is needed. The present study therefore focused on the development of a multiplex biosensing platform targeting lipopolysaccharide (LPS), c-reactive protein (CRP), and procalcitonin (PCT). The study designed a series of electrochemical sensors targeting the three selected biomarkers. Whilst all systems employed aptamers as the recognition element, a hybrid system combining aptamer and molecular imprinting technology was also developed for LPS. Following optimisation of sensor design, electrochemical impedance spectroscopy was used to evaluate performance (binding affinity (Kd), sensitivity, selectivity and dynamic range). Aptasensors were developed for all markers with varying degrees of success. Whilst the optimised aptasensors for LPS and CRP demonstrated good performance, the PCT aptasensor showed poor stability. Despite these issues however, a limit of detection (LOD) of ~ 25 pg/ml was achieved. LODs for LPS and CRP were 100 and 250 fg/ml respectively. The use of a hybrid imprinting approach further enhanced the performance of the LPS detection system, taking the LOD down to 1 fg/ml whilst also increasing binding capacity. Although aptamer-based sensing systems have been described for LPS and CRP, to the best of our knowledge, this is the first report of a such a system targeting PCT. The hybrid imprinting strategy exploited in the study has previously been demonstrated for prostate specific antigen, however this is the first report of such an approach being used for non-protein targets. The recognition of such molecules using conventional imprinting approaches has been largely unsuccessful; the method described herein should be translatable to other biologically relevant targets.
Supervisor: Not available Sponsor: Not available
Qualification Name: Thesis (Ph.D.) Qualification Level: Doctoral
EThOS ID: uk.bl.ethos.821737  DOI: Not available
Keywords: Q Science (General)
Share: